After Recurrent IVF Failure, How to Find a Breakthrough Through Overseas Treatment? — A Comprehensive Guide to Third-Generation IVF and PGT in Hong Kong

A Clinic Story

Ms. Liu (name withheld), a 39-year-old human resources director from Guangzhou, married at 35 and began trying to conceive shortly after. Over four years, she completed four IVF cycles at two well-known reproductive centers in mainland China — two fresh embryo transfers and two frozen embryo transfers — all ending in failure. Each time, the second line on the pregnancy test never appeared, like a wall repeatedly blocking her from becoming a mother.

"All the tests were done — hysteroscopy, immunology, chromosome analysis — and the doctors said everything was normal," Ms. Liu recalled. "But it just never worked. After each failure, they said 'try again,' but no one could tell me why."

In a patient support group, someone mentioned reproductive centers in Hong Kong that offer more comprehensive embryo genetic screening. Ms. Liu began researching and learned that some Hong Kong hospitals have more systematic diagnostic protocols for patients with recurrent IVF failure, including PGT-A (Preimplantation Genetic Testing for Aneuploidies) . She contacted the IVF Centre at Hong Kong Sanatorium & Hospital and traveled to Hong Kong with four years' worth of medical records.

During the initial consultation, the reproductive medicine specialist carefully reviewed her treatment history and identified a critical oversight: none of the embryos transferred in her previous four cycles had undergone chromosomal screening. Yet the rate of chromosomal abnormalities in eggs from women around age 40 can be as high as 50%–70% — meaning the embryos she had been transferring were likely "unhealthy seeds" that could not take root regardless of how favorable the uterine environment was.

The doctor recommended PGT-A in the new cycle — screening embryos for normal chromosome number before transfer. Ms. Liu agreed. After ovarian stimulation, 9 eggs were retrieved, 5 blastocysts were cultured, and PGT-A screening revealed that only 2 embryos had normal chromosomes — the other 3 had aneuploidies and would have had almost no chance of implantation even if transferred. One high-quality blastocyst was selected for transfer.

This time, she succeeded. Ms. Liu is now 28 weeks pregnant, with all fetal development progressing normally.

1. What Causes Recurrent IVF Failure?

Recurrent Implantation Failure (RIF) is generally defined as failure to achieve clinical pregnancy after three or more consecutive embryo transfers. The causes are complex and may involve multiple factors:

1. Embryonic factors are the primary cause. Chromosomal abnormalities are the most critical reason embryos fail to implant or result in early miscarriage. A normal human embryo should have 46 chromosomes. If the number is abnormal (e.g., Down syndrome), the embryo typically cannot implant or miscarries early. As women age, the rate of chromosomal abnormalities in eggs increases significantly — approximately 30%–40% in women under 35, rising to 60%–80% in women over 40.

2. Uterine environment and endometrial receptivity. Inadequate endometrial thickness (<7mm), displaced implantation windows, uterine fibroids, polyps, or adhesions can all affect implantation.

3. Immunological and coagulation factors. Some patients have autoimmune abnormalities or pre-thrombotic states that prevent implantation or cause recurrent miscarriage.

4. Sperm quality and DNA fragmentation. High sperm DNA fragmentation can affect embryo developmental potential — even if fertilization succeeds, the embryo may arrest at later stages.

5. Laboratory conditions and embryo culture systems. Every step of in vitro embryo culture — media, incubators, handling techniques — affects embryo quality and developmental potential.

Patients with multiple failures in mainland China often do not undergo systematic failure analysis in earlier cycles — they simply "repeat the same process and expect different results." The approach at some Hong Kong reproductive centers is: find the cause first, then design the protocol.

2. Why Choose Hong Kong? — A "Breakthrough" Strategy for Patients with Recurrent Failure

For patients who have experienced multiple IVF failures in mainland China, Hong Kong offers several key advantages:

1. Regulated and evidence-based application of PGT. Hong Kong's Human Reproductive Technology Ordinance provides clear ethical and operational guidelines for PGT. In Hong Kong, recurrent implantation failure (RIF) is a clear indication for PGT-A. Hong Kong Sanatorium & Hospital explicitly states that couples with "multiple IVF failures" are recommended for PGT-A. HEAL Fertility also lists "couples with repeated embryo transfer failure" as candidates for PGT-A. Third-generation IVF in Hong Kong is not available to everyone, but patients with clear indications — including advanced maternal age (≥35), two or more recurrent miscarriages, and multiple embryo transfer failures — are eligible for PGT screening.

2. Advanced embryology laboratories and culture systems. Top Hong Kong reproductive centers are generally equipped with advanced embryology laboratories using time-lapse imaging systems for continuous embryo monitoring. Hong Kong Sanatorium & Hospital has introduced AI-powered embryo dynamic monitoring systems for precise embryo selection. Some institutions achieve embryo freezing and thawing survival rates as high as 98%.

3. Personalized protocol adjustments. For patients with recurrent failure, Hong Kong doctors tend to conduct comprehensive investigations before designing individualized protocols — adjusting stimulation medications and dosages based on the patient's age, AMH, and prior responses, and combining with ERA (Endometrial Receptivity Array) when necessary to identify the optimal implantation window.

4. International standards and multidisciplinary collaboration. Hong Kong reproductive centers generally follow internationally recognized laboratory standards (e.g., ISO15189), with teams typically including reproductive medicine specialists, embryologists, genetic counselors, and others capable of multidimensional evaluation of complex cases.

3. PGT-A in Hong Kong: "Precision Screening" for Patients with Recurrent Failure

For patients with recurrent IVF failure, PGT-A (Preimplantation Genetic Testing for Aneuploidies) is the most critical technological breakthrough.

What does PGT-A do? When embryos reach the blastocyst stage on day 5–6 of culture, embryologists use micro-laser technology to precisely extract 5–10 trophectoderm cells for genetic testing. The goal is to confirm whether the embryo has the normal chromosome number of 46 (euploid) and to screen out embryos with abnormal chromosome numbers (aneuploid).

Why is this important for patients with recurrent failure? In many cases of recurrent implantation failure, the problem is precisely that "chromosomally abnormal embryos were transferred" — embryos that look morphologically normal under the microscope but have fatal chromosomal defects that make implantation impossible or inevitably lead to miscarriage. PGT-A can identify these "invisibly problematic embryos" at the genetic level, avoiding ineffective transfers.

Indications: Major reproductive centers in Hong Kong generally list the following as indications for PGT-A — advanced maternal age (≥35), recurrent pregnancy loss (≥3), recurrent implantation failure (≥3), and severe male factor infertility.

4. Major Reproductive Medicine Centers in Hong Kong

Hong Kong Sanatorium & Hospital (HKSH) IVF Centre

One of Hong Kong's oldest private reproductive centers, equipped with AI embryo dynamic monitoring systems. HKSH was among the first in Hong Kong to apply NGS technology to PGT, with PGT-A cases achieving a 67% pregnancy rate. Third-generation IVF success rates reach 78%–85%. Particularly suitable for complex cases including advanced maternal age and recurrent failure. Costs approximately HKD 250,000–300,000 per cycle (including PGT).

CUHK Fertility Centre, Prince of Wales Hospital

The first assisted reproduction center in Hong Kong to receive ISO 9001 certification. Offers a mature PGT testing system and collaborates with institutions like HEAL Fertility to provide embryo genetic testing services. Clinical pregnancy rates for patients under 35 reach 68%. Public hospital costs are lower (approximately HKD 80,000–120,000), but waiting times can reach 8–12 months.

HEAL Fertility

Offers comprehensive PGT-A, PGT-M, and PGT-SR testing services. Third-generation IVF package costs approximately HKD 168,000. Flexible services with short appointment lead times.

Queen Mary Hospital Assisted Reproduction Centre

A teaching hospital of the University of Hong Kong, with extensive experience in managing complex conditions including recurrent implantation failure. Public hospital costs approximately HKD 80,000–140,000.

5. Treatment Pathway and Practical Recommendations

Step 1: Online consultation and document preparation. Make initial contact with a Hong Kong reproductive center via email or video consultation, submitting all previous treatment records (stimulation protocols, eggs retrieved, fertilization rates, embryo grades, number of transfers, etc.).

Step 2: Initial consultation and comprehensive assessment in Hong Kong. The doctor systematically reviews the history and may order additional tests (hormones, AMH, hysteroscopy, immunological markers, etc.) before designing an individualized new protocol.

Step 3: Start the new cycle. Choose a stimulation protocol based on assessment results. For patients with recurrent failure, doctors may recommend mild stimulation to reduce ovarian burden, or combine with ERA testing to identify the personalized implantation window.

Step 4: PGT screening and frozen embryo transfer. After embryos reach the blastocyst stage, biopsy samples are sent for testing — results typically take 1–2 weeks. Normal embryos are cryopreserved and transferred in a subsequent frozen cycle.

Practical recommendations:

• Bring all previous medical records — the more detailed, the better; this is the foundation for designing a new protocol

• Clearly inform the doctor of the number of failures and details of each — including embryo grades and post-transfer uterine conditions

• Maintain realistic expectations about PGT — PGT can screen out abnormal embryos but cannot create them; egg yield and blastocyst number remain prerequisites

• Allow sufficient time and budget — PGT cycles typically take 2–3 weeks longer than conventional cycles due to the waiting time for screening results

Recurrent IVF failure does not mean the end of fertility hopes. Through systematic investigation of failure causes, introduction of precision screening technologies like PGT, and selection of experienced medical teams, many patients have successfully achieved pregnancy overseas. If you are facing the challenges of recurrent IVF failure and would like to learn about personalized overseas treatment options, please feel free to contact us. We will provide professional consultation and assessment tailored to your situation.